Brand Name | Status | Last Update |
---|---|---|
animi-3 | unapproved drug other | 2013-02-06 |
animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
bal-care dha | unapproved drug other | 2012-05-01 |
bal-care dha essential | unapproved drug other | 2012-05-01 |
bp vit 3 | unapproved drug other | 2023-10-11 |
c-nate dha | unapproved drug other | 2024-01-22 |
citranatal 90 dha | unapproved drug other | 2024-01-08 |
citranatal assure | unapproved drug other | 2024-01-08 |
citranatal bloom dha | unapproved drug other | 2020-04-06 |
citranatal dha | unapproved drug other | 2020-07-28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | — | 7 | 5 | 2 | 18 | 30 |
Hypertriglyceridemia | D015228 | EFO_0004211 | — | 4 | 3 | 9 | 4 | 8 | 27 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 3 | 6 | 3 | 11 | 22 |
Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 1 | 1 | 1 | 12 | 16 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | 2 | 1 | 9 | 14 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | 3 | 3 | 1 | 3 | 9 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | 3 | — | 2 | 4 | 9 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 3 | — | 1 | 4 | 8 |
Child development | D002657 | — | — | — | 2 | 1 | 1 | 5 | 8 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | 5 | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | 1 | 2 | — | 18 | 26 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 4 | 1 | — | 7 | 16 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | 1 | 6 | — | 6 | 14 |
Depression | D003863 | — | F33.9 | — | 4 | 5 | — | 4 | 12 |
Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | 1 | 3 | — | 6 | 10 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 2 | 2 | — | 6 | 9 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | 1 | — | 1 | — | 6 | 8 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | 1 | — | 4 | 6 |
Dry eye syndromes | D015352 | — | H04.12 | — | — | 1 | — | 5 | 6 |
Overweight | D050177 | — | E66.3 | 2 | 2 | 1 | — | 2 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | 1 | 1 | — | — | 3 | 5 |
Dyslipidemias | D050171 | HP_0003119 | — | 1 | 1 | — | — | 3 | 5 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | — | 3 | — | — | 2 | 5 |
Periodontitis | D010518 | EFO_0000649 | K05.3 | — | 1 | — | — | 3 | 4 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | 1 | — | — | 2 | 3 |
Pregnancy rate | D018873 | — | — | — | 1 | — | — | 2 | 3 |
Follicular lymphoma | D008224 | — | C82 | 1 | 1 | — | — | — | 2 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | — | — | 1 | 2 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 1 | — | — | — | 2 |
Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Insulin resistance | D007333 | HP_0000855 | E88.819 | 1 | — | — | — | 4 | 5 |
Hypercholesterolemia | D006937 | HP_0003124 | — | 1 | — | — | — | 3 | 4 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | 1 | — | — | — | 3 | 4 |
Pregnancy-induced hypertension | D046110 | — | O13 | 1 | — | — | — | 2 | 3 |
Gestational diabetes | D016640 | HP_0009800 | O24.4 | 1 | — | — | — | 2 | 3 |
Brain concussion | D001924 | — | S06.0 | 1 | — | — | — | 1 | 2 |
Healthy diet | D000072001 | — | — | 1 | — | — | — | 1 | 2 |
Female infertility | D007247 | EFO_0008560 | N97 | 1 | — | — | — | — | 1 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Phenylketonurias | D010661 | — | E70.0 | — | — | — | — | 7 | 7 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | — | 5 | 5 |
Affect | D000339 | — | — | — | — | — | — | 4 | 4 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 3 | 3 |
Breast feeding | D001942 | — | — | — | — | — | — | 3 | 3 |
Muscular atrophy | D009133 | HP_0003202 | — | — | — | — | — | 3 | 3 |
Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | — | 2 | 2 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | — | — | 2 | 2 |
Bone density | D015519 | EFO_0003923 | M85 | — | — | — | — | 2 | 2 |
Cerebrovascular circulation | D002560 | — | — | — | — | — | — | 2 | 2 |
Drug common name | Doconexent |
INN | doconexent |
Description | All-cis-docosa-4,7,10,13,16,19-hexaenoic acid is a docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. It has a role as a nutraceutical, an antineoplastic agent, a human metabolite, a Daphnia tenebrosa metabolite, a mouse metabolite and an algal metabolite. It is a docosahexaenoic acid and an omega-3 fatty acid. It is a conjugate acid of a (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O |
PDB | — |
CAS-ID | 6217-54-5 |
RxCUI | — |
ChEMBL ID | CHEMBL367149 |
ChEBI ID | 28125 |
PubChem CID | 445580 |
DrugBank | DB03756 |
UNII ID | ZAD9OKH9JC (ChemIDplus, GSRS) |